Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

• Status: Unknown status
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this trial is to investigate the effect of early treatment of glucose toxicity with acarbose, a drug to control postprandial hyperglycemia, on the occurence of cardiovascular events and the inhibition of atherosclerosis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aichi Gakuin University
• Treatments: Acarbose

Criteria

Inclusion Criteria:

• Patients who have been diagnosed with coronary artery disease, with type 2 diabetes or impaired glucose tolerance

Exclusion Criteria:

• Patients scheduled to undergo revascularization at the time of enrollment

• Patients who are being treated with an oral hypoglycemic drug or an insulin preparation

• Patients with a history of laparotomy of ileus

• Pre- and postoperative patients or individuals with severe infection or serious trauma

• Patients with gastrointestinal disorders such as diarrhea and vomiting

• Patients with a history of hypersensitivity to acarbose

• Pregnant or possibly pregnant women

• Patients who are judged by the attending physician to be otherwise ineligible